Searchable abstracts of presentations at key conferences in endocrinology

ea0032p334 | Developmental Endocrinology | ECE2013

Somatostatin receptor sst2 transfer in somatolactotroph cell line. Constitutive activity and drug sensitivity

Roche Catherine , Graillon Thomas , Rasolonjanahary Ramahefarizo , Thirion Sylvie , Enjalbert Alain , Gerard Corinne , Barlier Anne

Somatostatin is a ubiquitous neuropeptidic inhibitor of various cellular functions including endocrine and exocrine secretion. Moreover, this peptide may control cell proliferation in normal and tumoral tissues. Somatostatin biological effects are mediated by five subtype of G protein-coupled receptor, sst1 through sst5. The somatostatin analogs have high affinity for sst2 receptor and the success of in vivo peptide therapy is correlated with high levels of sst2 in th...

ea0016s20.1 | Translational highlights | ECE2008

sst2 gene transfer restores the somatostatin agonist sensitivity of human resistant pituitary adenomas, in vitro

Acunzo Julie , Roche Catherine , Thirion Sylvie , Gunz Ginette , Saveanu Alexandru , Germanetti Anne Laure , Fusco Alessandra , Couderc Bettina , Enjalbert Alain , Barlier Anne

Somatotroph adenoma represent 20% of pituitary adenoma. Although often considered as benign, they can induce serious neurological and metabolic complications. GH hypersecretion can be inhibited by somatostatin agonists such as octreotide or lanreotide. However, some GH levels reach normal values in only 50% of treated patiens. The decreased sensitivity to the somatostatin agonists was shown to be related to a lower expression of the sst2 gene.To reverse ...